Screener

Revenue

Name: Acadia Pharmaceuticals Revenue by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Acadia Pharmaceuticals·Products & Services·2 segments·Rolls up to Total Revenue

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Nuplazid	$159.72M	$168.48M	$177.53M	$174.36M	$166.92M	$183.13M
Daybue	$84.6M	$96.09M	$101.1M	$109.63M	$101.14M	$124.83M
Total	$244.32M	$264.57M	$278.63M	$283.99M	$268.06M	$307.96M